Alpha Windward’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,034
| Closed | -$349K | – | 257 |
|
|
2020
Q3 | $349K | Buy |
10,034
+1,081
| +12% | +$37.9K | 0.25% | 183 |
|
|
2020
Q2 | $278K | Buy |
8,953
+302
| +3% | +$10.3K | 0.21% | 209 |
|
|
2020
Q1 | $268K | Buy |
8,651
+139
| +2% | +$4.74K | 0.24% | 170 |
|
|
2019
Q4 | $316K | Buy |
8,512
+97
| +1% | +$3.46K | 0.2% | 205 |
|
|
2019
Q3 | $287K | Buy |
8,415
+10
| +0.1% | +$364 | 0.19% | 211 |
|
|
2019
Q2 | $331K | Sell |
8,405
-63
| -0.7% | -$2.5K | 0.21% | 191 |
|
|
2019
Q1 | $341K | Sell |
8,468
-11,736
| -58% | -$470K | 0.23% | 180 |
|
|
2018
Q4 | $837K | Buy |
20,204
+10,801
| +115% | +$448K | 0.61% | 13 |
|
|
2018
Q3 | $393K | Sell |
9,403
-217
| -2% | -$8.35K | 0.24% | 174 |
|
|
2018
Q2 | $331K | Sell |
9,620
-6
| -0.1% | -$205 | 0.2% | 189 |
|
|
2018
Q1 | $324K | Buy |
9,626
+156
| +2% | +$5.36K | 0.2% | 189 |
|
|
2017
Q4 | $325K | Sell |
9,470
-150
| -2% | -$5.12K | 0.19% | 192 |
|
|
2017
Q3 | $326K | Hold |
9,620
| – | – | 0.2% | 184 |
|
|
2017
Q2 | $307K | Buy |
9,620
+780
| +9% | +$24.6K | 0.2% | 195 |
|
|
2017
Q1 | $287K | Buy |
8,840
+94
| +1% | +$2.96K | 0.19% | 194 |
|
|
2016
Q4 | $270K | Sell |
8,746
-18
| -0.2% | -$550 | 0.18% | 199 |
|
|
2016
Q3 | $282K | Buy |
8,764
+42
| +0.5% | +$1.4K | 0.2% | 190 |
|
|
2016
Q2 | $291K | Sell |
8,722
-345
| -4% | -$11K | 0.21% | 182 |
|
|
2016
Q1 | $255K | Sell |
9,067
-20
| -0.2% | -$571 | 0.18% | 194 |
|
|
2015
Q4 | $278K | Sell |
9,087
-114
| -1% | -$3.59K | 0.2% | 186 |
|
|
2015
Q3 | $274K | Sell |
9,201
-171
| -2% | -$5.48K | 0.2% | 181 |
|
|
2015
Q2 | $298K | Buy |
9,372
+541
| +6% | +$17.6K | 0.2% | 177 |
|
|
2015
Q1 | $292K | Sell |
8,831
-65
| -0.7% | -$2.07K | 0.19% | 186 |
|
|
2014
Q4 | $263K | Buy |
8,896
+792
| +10% | +$22.7K | 0.17% | 210 |
|
|
2014
Q3 | $227K | Sell |
8,104
-15
| -0.2% | -$421 | 0.16% | 210 |
|
|
2014
Q2 | $229K | Buy |
8,119
+3
| +0% | +$86 | 0.15% | 212 |
|
|
2014
Q1 | $247K | Sell |
8,116
-75
| -0.9% | -$2.24K | 0.17% | 194 |
|
|
2013
Q4 | $238K | Sell |
8,191
-41
| -0.5% | -$1.19K | 0.16% | 209 |
|
|
2013
Q3 | $224K | Buy |
8,232
+107
| +1% | +$2.91K | 0.17% | 199 |
|
|
2013
Q2 | $216K | Buy |
+8,125
| New | +$224K | 0.17% | 197 |
|
Other funds holding PFE
Alpha Windward's PFE Position: Q4 2020 in Review
Alpha Windward sold out of Pfizer (PFE) in Q4 2020, closing a stake of 10,034 shares — an estimated $349K sold.
Alpha Windward first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $837K in Q4 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Alpha Windward reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
- Alpha Windward sold 10,034 Pfizer shares in Q4 2020, an estimated $349K.
- Alpha Windward first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- Alpha Windward's Pfizer position peaked at $837K in Q4 2018.
- 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Alpha Windward's 13F filing for Q4 2020.